Veterinary Stents Market Size, Share & Trends Analysis Report by Product, by Applications, by Regions and Segment Forecasts, 2024 - 2034
Emergen Research has taken another significant step in strengthening its position as a trusted provider of market intelligence by introducing its latest Veterinary Stents market research content. This comprehensive offering is designed to help businesses better understand complex market dynamics while equipping them with the tools needed to make confident and strategic decisions.
Veterinary Stents Market Size and Overview
The Veterinary Stents market is expected to grow from an estimated USD 310.1 billion in 2024 to USD 510.7 billion in 2033, at a CAGR of 5.70%.
The global Veterinary Stents market size is expected to grow from 310.1 billion by the end of 2024 to 510.7 billion by 2033, registering a revenue CAGR of 5.70% during the forecast period. The major Veterinary Stents market growth factors are the advancements in veterinary technology and the growing preference for disposable consumables. The primary driver of veterinary stent growth is an increase in the number of veterinary diseases.
As health issues in pets and livestock, particularly in the cardiovascular and urinary systems, increase, so does the demand for appropriate treatments, such as stents, resulting in increased consumable consumption because veterinarians require a reliable means of managing such conditions. The growing awareness among pet owners about animal health and the importance of medical care created a high demand for stent procedures.
Aside from that, advancements in veterinary medicine and technology have made stent procedures more accessible and effective, which encourages veterinarians to use consumables. For instance, according to data published by PLOS in 2021, the prevalence of bovine tuberculosis was estimated to be 2.4% in China, 7.3% in India, and 2.87 in Spain.
According to a study published on Research Gate, approximately 10.0% to 15.0% of all dogs worldwide suffer from heart disease.
Furthermore, advancements in veterinary technology are another driver of veterinary stent growth. Innovations in material science and design have resulted in stents that are more effective, durable, and implantable. These developments improve the safety and efficacy of procedures, encouraging veterinarians to use stents as part of treatment plans for a variety of conditions.
Furthermore, imaging and minimally invasive techniques have improved stent placement and monitoring, resulting in faster animal recovery times. New stent technologies that address specific needs in veterinary medicine are emerging as a result of ongoing research. This consistent innovation not only improves patient outcomes but also boosts confidence among veterinarians in general, propelling the veterinary stents market as more veterinary practitioners adopt these advanced solutions for the animals in their care. For instance, in January 2024, the AVMA published a clinical study to investigate the efficacy of Dumon silicone stents for improving respiratory function in dogs with grade IV tracheal collapse (TC).
Boston Medical Products Inc. manufactures Dumon silicone stents, which are used in humans to treat airway stenosis. The AVMA study found that when used in dogs, these stents are an effective treatment for TC when medical management fails. As a result, the advancements in veterinary technology are driving the expansion of the veterinary stents market.
At the heart of this research lies a strong focus on delivering value to a diverse audience. The report is particularly useful for key market players, investors, venture capitalists, and organizations of all sizes, ranging from startups to large enterprises. Additionally, research institutions, consulting firms, and government bodies can leverage the insights provided to support planning, policy-making, and strategic initiatives.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4234
Emergen Research has taken another significant step in strengthening its position as a trusted provider of market intelligence by introducing its latest Veterinary Stents market research content. This comprehensive offering is designed to help businesses better understand complex market dynamics while equipping them with the tools needed to make confident and strategic decisions.
Veterinary Stents Market Size and Overview
The Veterinary Stents market is expected to grow from an estimated USD 310.1 billion in 2024 to USD 510.7 billion in 2033, at a CAGR of 5.70%.
The global Veterinary Stents market size is expected to grow from 310.1 billion by the end of 2024 to 510.7 billion by 2033, registering a revenue CAGR of 5.70% during the forecast period. The major Veterinary Stents market growth factors are the advancements in veterinary technology and the growing preference for disposable consumables. The primary driver of veterinary stent growth is an increase in the number of veterinary diseases.
As health issues in pets and livestock, particularly in the cardiovascular and urinary systems, increase, so does the demand for appropriate treatments, such as stents, resulting in increased consumable consumption because veterinarians require a reliable means of managing such conditions. The growing awareness among pet owners about animal health and the importance of medical care created a high demand for stent procedures.
Aside from that, advancements in veterinary medicine and technology have made stent procedures more accessible and effective, which encourages veterinarians to use consumables. For instance, according to data published by PLOS in 2021, the prevalence of bovine tuberculosis was estimated to be 2.4% in China, 7.3% in India, and 2.87 in Spain.
According to a study published on Research Gate, approximately 10.0% to 15.0% of all dogs worldwide suffer from heart disease.
Furthermore, advancements in veterinary technology are another driver of veterinary stent growth. Innovations in material science and design have resulted in stents that are more effective, durable, and implantable. These developments improve the safety and efficacy of procedures, encouraging veterinarians to use stents as part of treatment plans for a variety of conditions.
Furthermore, imaging and minimally invasive techniques have improved stent placement and monitoring, resulting in faster animal recovery times. New stent technologies that address specific needs in veterinary medicine are emerging as a result of ongoing research. This consistent innovation not only improves patient outcomes but also boosts confidence among veterinarians in general, propelling the veterinary stents market as more veterinary practitioners adopt these advanced solutions for the animals in their care. For instance, in January 2024, the AVMA published a clinical study to investigate the efficacy of Dumon silicone stents for improving respiratory function in dogs with grade IV tracheal collapse (TC).
Boston Medical Products Inc. manufactures Dumon silicone stents, which are used in humans to treat airway stenosis. The AVMA study found that when used in dogs, these stents are an effective treatment for TC when medical management fails. As a result, the advancements in veterinary technology are driving the expansion of the veterinary stents market.
At the heart of this research lies a strong focus on delivering value to a diverse audience. The report is particularly useful for key market players, investors, venture capitalists, and organizations of all sizes, ranging from startups to large enterprises. Additionally, research institutions, consulting firms, and government bodies can leverage the insights provided to support planning, policy-making, and strategic initiatives.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4234
Veterinary Stents Market Size, Share & Trends Analysis Report by Product, by Applications, by Regions and Segment Forecasts, 2024 - 2034
Emergen Research has taken another significant step in strengthening its position as a trusted provider of market intelligence by introducing its latest Veterinary Stents market research content. This comprehensive offering is designed to help businesses better understand complex market dynamics while equipping them with the tools needed to make confident and strategic decisions.
Veterinary Stents Market Size and Overview
The Veterinary Stents market is expected to grow from an estimated USD 310.1 billion in 2024 to USD 510.7 billion in 2033, at a CAGR of 5.70%.
The global Veterinary Stents market size is expected to grow from 310.1 billion by the end of 2024 to 510.7 billion by 2033, registering a revenue CAGR of 5.70% during the forecast period. The major Veterinary Stents market growth factors are the advancements in veterinary technology and the growing preference for disposable consumables. The primary driver of veterinary stent growth is an increase in the number of veterinary diseases.
As health issues in pets and livestock, particularly in the cardiovascular and urinary systems, increase, so does the demand for appropriate treatments, such as stents, resulting in increased consumable consumption because veterinarians require a reliable means of managing such conditions. The growing awareness among pet owners about animal health and the importance of medical care created a high demand for stent procedures.
Aside from that, advancements in veterinary medicine and technology have made stent procedures more accessible and effective, which encourages veterinarians to use consumables. For instance, according to data published by PLOS in 2021, the prevalence of bovine tuberculosis was estimated to be 2.4% in China, 7.3% in India, and 2.87 in Spain.
According to a study published on Research Gate, approximately 10.0% to 15.0% of all dogs worldwide suffer from heart disease.
Furthermore, advancements in veterinary technology are another driver of veterinary stent growth. Innovations in material science and design have resulted in stents that are more effective, durable, and implantable. These developments improve the safety and efficacy of procedures, encouraging veterinarians to use stents as part of treatment plans for a variety of conditions.
Furthermore, imaging and minimally invasive techniques have improved stent placement and monitoring, resulting in faster animal recovery times. New stent technologies that address specific needs in veterinary medicine are emerging as a result of ongoing research. This consistent innovation not only improves patient outcomes but also boosts confidence among veterinarians in general, propelling the veterinary stents market as more veterinary practitioners adopt these advanced solutions for the animals in their care. For instance, in January 2024, the AVMA published a clinical study to investigate the efficacy of Dumon silicone stents for improving respiratory function in dogs with grade IV tracheal collapse (TC).
Boston Medical Products Inc. manufactures Dumon silicone stents, which are used in humans to treat airway stenosis. The AVMA study found that when used in dogs, these stents are an effective treatment for TC when medical management fails. As a result, the advancements in veterinary technology are driving the expansion of the veterinary stents market.
At the heart of this research lies a strong focus on delivering value to a diverse audience. The report is particularly useful for key market players, investors, venture capitalists, and organizations of all sizes, ranging from startups to large enterprises. Additionally, research institutions, consulting firms, and government bodies can leverage the insights provided to support planning, policy-making, and strategic initiatives.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4234
0 Comments
0 Shares